GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Works Technologies AB (XSAT:BIOWKS) » Definitions » Asset Turnover

Bio-Works Technologies AB (XSAT:BIOWKS) Asset Turnover : 0.04 (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Bio-Works Technologies AB Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Bio-Works Technologies AB's Revenue for the three months ended in Dec. 2024 was kr2.65 Mil. Bio-Works Technologies AB's Total Assets for the quarter that ended in Dec. 2024 was kr59.71 Mil. Therefore, Bio-Works Technologies AB's Asset Turnover for the quarter that ended in Dec. 2024 was 0.04.

Asset Turnover is linked to ROE % through Du Pont Formula. Bio-Works Technologies AB's annualized ROE % for the quarter that ended in Dec. 2024 was -102.97%. It is also linked to ROA % through Du Pont Formula. Bio-Works Technologies AB's annualized ROA % for the quarter that ended in Dec. 2024 was -88.14%.


Bio-Works Technologies AB Asset Turnover Historical Data

The historical data trend for Bio-Works Technologies AB's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Works Technologies AB Asset Turnover Chart

Bio-Works Technologies AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.26 0.39 0.57 0.44

Bio-Works Technologies AB Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.24 - 0.19 0.04

Competitive Comparison of Bio-Works Technologies AB's Asset Turnover

For the Biotechnology subindustry, Bio-Works Technologies AB's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Works Technologies AB's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Works Technologies AB's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Bio-Works Technologies AB's Asset Turnover falls into.


;
;

Bio-Works Technologies AB Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Bio-Works Technologies AB's Asset Turnover for the fiscal year that ended in Dec. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=25.465/( (62.152+52.497)/ 2 )
=25.465/57.3245
=0.44

Bio-Works Technologies AB's Asset Turnover for the quarter that ended in Dec. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=2.645/( (66.922+52.497)/ 2 )
=2.645/59.7095
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Bio-Works Technologies AB  (XSAT:BIOWKS) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Bio-Works Technologies AB's annulized ROE % for the quarter that ended in Dec. 2024 is

ROE %**(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=-52.628/51.11
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-52.628 / 10.58)*(10.58 / 59.7095)*(59.7095/ 51.11)
=Net Margin %*Asset Turnover*Equity Multiplier
=-497.43 %*0.1772*1.1683
=ROA %*Equity Multiplier
=-88.14 %*1.1683
=-102.97 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Bio-Works Technologies AB's annulized ROA % for the quarter that ended in Dec. 2024 is

ROA %(Q: Dec. 2024 )
=Net Income/Total Assets
=-52.628/59.7095
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-52.628 / 10.58)*(10.58 / 59.7095)
=Net Margin %*Asset Turnover
=-497.43 %*0.1772
=-88.14 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Bio-Works Technologies AB Asset Turnover Related Terms

Thank you for viewing the detailed overview of Bio-Works Technologies AB's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Works Technologies AB Business Description

Traded in Other Exchanges
N/A
Address
Virdings alle 18, Uppsala, SWE, 75450
Bio-Works Technologies AB is a Sweden-based life science company which is engaged in designing, developing, manufacturing and supplying products for purification and separation of proteins and other molecules. The product line of the company includes activated resin, immobilized metal-ion affinity chromatography resin, ion exchange chromatography resin, size exclusion chromatography resin and others. The company has also developed affinity chromatography technique, BabyBio Columns, OptiBio glass columns for separating proteins, and protein purification. Bio-Works serves various end users such as academic research laboratories, biopharmaceutical companies, the food and beverage industry and others.

Bio-Works Technologies AB Headlines

No Headlines